Skip to main content
. 2019 Oct 18;2019(10):CD001233. doi: 10.1002/14651858.CD001233.pub3

Comparison 29. EASI versus intracervical prostaglandin E2: all women.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Caesarean section 2 155 Risk Ratio (M‐H, Random, 95% CI) 0.73 [0.10, 5.12]
2 Cervix unfavourable/unchanged after 12‐24 hours 1 85 Risk Ratio (M‐H, Fixed, 95% CI) 0.06 [0.00, 0.97]
3 Oxytocin augmentation 1 70 Risk Ratio (M‐H, Fixed, 95% CI) 1.1 [0.54, 2.25]
4 Instrumental vaginal delivery 1 85 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.04, 3.01]
5 Apgar score < 7 at 5 minutes 1 85 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Endometritis 1 85 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Fetal distress 1 70 Risk Ratio (M‐H, Fixed, 95% CI) 0.29 [0.06, 1.28]